Drug Shortage Report for NOREPINEPHRINE BITARTRATE INJECTION USP

Last updated on 2018-01-18 History
Report ID 35329
Drug Identification Number 00893285
Brand name NOREPINEPHRINE BITARTRATE INJ 1MG/ML USP
Common or Proper name NOEPINEPHRINE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) NOREPINEPHRINE
Strength(s) 1MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10 x 4ML VIALS
ATC code C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Demand increase for the drug.
Anticipated start date 2018-01-12
Actual start date 2018-01-12
Estimated end date 2018-01-19
Actual end date 2018-01-16
Shortage status Resolved
Updated date 2018-01-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2018-01-18 French Compare
v4 2018-01-18 English Compare
v3 2018-01-13 English Compare
v2 2018-01-08 French Compare
v1 2018-01-08 English Compare

Showing 1 to 5 of 5